Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-11

Clinical Trial Update: Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating OmegaD Softgels for dry eye disease has been completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OmegaD Softgels

Snippet

Sponsor: OmegaD LLC | Conditions: Dry Eye | Phase 3 | Status: COMPLETED | Results posted: 2019-09-11